Mindray's Q2 Results Disappoint Investors: Weaker China Growth Due To Slowdown In Government Tender
This article was originally published in The Pink Sheet Daily
Executive Summary
The Chinese device maker remains optimistic about government spending over the long term, as the Chinese government has made no change to its stated three-year health care reform plan or the associated budgets for each category under the plan, exec says.